Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LBH domain containing 2 (LBHD2) is a protein encoded by the LBHD2 gene in humans[7]. The gene is protein-coding and has been assigned gene identifiers including HGNC: 52384 and NCBI Gene: 107984640[7]. LBHD2 is classified as a protein with an LBH (Limb-Bud and Heart) domain, though its molecular function, pathway participation, and roles in disease remain largely uncharacterized[3][7]. According to mouse studies, the protein may have a role in brain development, but functional and mechanistic data are not available[8][6][7]. There are currently no reports describing it as a known receptor, enzyme, transporter, or other classical drug target, nor any drugs, disease associations, or safety considerations related to this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LBH domain containing 2 (LBHD2).